Amerise Biosciences quarterly results and financials

Amerise Biosciences (BSE 531681)₹0.8100−3.57%(9 Nov 2026 close)Plastic Products - Industrial

Key facts

In the Jun 2026 quarter (standalone), Amerise Biosciences reported sales of ₹0 Cr, down 100.0% from Jun 2025, and net profit of −₹0.09 Cr. For the year to Mar 2026, sales were ₹0.27 Cr and net profit ₹0.03 Cr.

Sales (Jun 2026): ₹0 Cr
Net profit (Jun 2026): −₹0.09 Cr
Sales (FY Mar 2026): ₹0.27 Cr
Net profit (FY Mar 2026): ₹0.03 Cr
EPS (Jun 2026): ₹−0.02
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Amerise Biosciences quarterly results

₹ crore unless stated; each column is a quarter.

Amerise Biosciences Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	0.00	0.05	0.00	0.00	0.00	0.20	0.07	0.08	0.05	0.09	0.00
Expenses	0.05	0.07	0.03	0.06	0.04	0.03	0.09	0.08	0.12	0.04	0.03	0.09
Operating Profit	−0.05	−0.05	0.03	−0.06	−0.04	−0.03	0.12	−0.02	−0.05	0.02	0.07	−0.09
OPM %	—	—	50.0%	—	—	—	57.9%	−16.7%	−57.1%	25.0%	75.0%	—
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.03	−0.05	0.01	−0.04	−0.02	−0.01	0.10	0.00	−0.03	0.00	0.05	−0.07
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	−0.03	−0.05	0.03	−0.04	−0.02	−0.03	0.12	−0.02	−0.03	0.02	0.07	−0.09
EPS (Rs)	−0.02	−0.02	0.00	−0.02	0.00	0.00	0.03	0.00	−0.02	0.00	0.02	−0.02

Amerise Biosciences profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Amerise Biosciences Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.00	0.00	0.00	1.19	0.00	0.00	9.59	0.02	0.05	0.20	0.27	0.22
Expenses	0.04	0.95	0.03	1.19	0.16	0.18	9.06	0.14	0.20	0.19	0.25	0.28
Operating Profit	−0.04	−0.95	−0.03	0.00	−0.16	−0.18	0.56	−0.13	−0.16	0.02	0.03	−0.05
OPM %	—	—	—	0.0%	—	—	5.8%	−1,200.0%	−375.0%	5.3%	7.7%	−22.7%
Other Income	0.00	0.00	0.00	0.00	0.00	−0.16	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.02	−0.93	−0.01	0.00	−0.14	−0.33	0.54	−0.11	−0.14	0.00	0.01	−0.05
Tax %	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—
Net Profit	−0.04	−0.95	−0.01	0.00	−0.16	−0.35	0.54	−0.13	−0.16	0.02	0.03	−0.03
EPS (Rs)	0.00	−0.15	0.00	0.00	−0.03	−0.06	0.09	−0.03	−0.03	0.00	0.00	−0.02
Dividend payout %	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Amerise Biosciences balance sheet

₹ crore, at each year end.

Amerise Biosciences Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6.60	6.59	6.59	6.59	6.60	6.59	6.59	6.59	6.60	6.59	6.61	6.60
Reserves	−0.04	−0.06	−1.00	−1.02	−1.02	−1.17	−1.51	−0.96	−1.08	−1.22	−1.22	−1.20
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.08	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.05	0.02	0.03	0.60	0.55	6.30	0.05	0.02	3.09	2.03
Total Liabilities	6.56	6.53	5.64	5.59	5.61	6.02	5.63	12.00	5.65	5.39	8.48	7.43
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	4.81	5.87	2.33	2.30	0.53	5.35	3.03	4.68	4.56	2.26	2.37	3.76
Other Assets	1.75	0.66	3.31	3.29	5.08	0.67	2.60	7.32	1.09	3.13	6.11	3.67
Trade receivables	0.00	0.00	2.68	2.68	4.46	0.00	0.00	6.21	0.00	0.00	0.00	0.00
Cash & equivalents	0.06	0.07	0.05	0.04	0.03	0.04	0.03	0.02	0.02	0.03	0.03	0.60
Total Assets	6.56	6.53	5.64	5.59	5.61	6.02	5.63	12.00	5.65	5.39	8.48	7.43

Amerise Biosciences cash flow

₹ crore, for each year.

Amerise Biosciences Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.28	1.09	−3.57	−0.05	−1.79	4.90	−0.40	0.07	−0.14	−0.18	3.08	−1.07
Cash from investing activity	0.33	−1.08	3.56	0.02	1.78	−4.90	0.38	−0.14	0.12	0.28	−3.06	1.62
Cash from financing activity	−0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.02	−0.10	0.00	0.00
Net cash flow	0.00	0.00	−0.02	−0.02	−0.02	0.02	−0.02	−0.02	0.00	0.02	0.00	0.58
Free cash flow	0.28	1.09	−3.57	−0.05	−1.79	4.90	−0.40	0.07	−0.14	−0.18	3.08	−1.07
CFO / OP %	−540.1%	−3,600.0%	379.0%	199.9%	—	−3,260.1%	229.0%	11.0%	107.9%	112.9%	30,700.0%	−5,300.0%

Amerise Biosciences ratios

Working-capital days and returns, by year.

Amerise Biosciences Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	—	—	—	—	1,384	—	—	238	0	0	0	0
Inventory days	—	—	—	—	0	—	—	0	—	—	—	—
Cash conversion cycle	—	—	—	—	1,382	—	—	236	0	0	0	0
Working capital days	—	—	—	—	1,376	—	—	−2	−1,460	−182	−5,898	−2,822
ROCE %	−0.7%	−0.5%	−15.5%	−0.4%	0.0%	−2.7%	−6.5%	10.2%	−2.1%	−2.8%	0.2%	0.4%

Amerise Biosciences: frequently asked questions

What are the latest quarterly results of Amerise Biosciences?

For the Jun 2026 quarter, Amerise Biosciences reported sales of ₹0 Cr, down 100.0% year on year and net profit of −₹0.09 Cr.

What is the annual revenue of Amerise Biosciences?

Amerise Biosciences' sales for the year to Mar 2026 were ₹0.27 Cr; over the last twelve months they were ₹0.22 Cr.

What is the net profit of Amerise Biosciences?

Net profit for the year to Mar 2026 was ₹0.03 Cr, and −₹0.03 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.02.

How much debt does Amerise Biosciences have?

Amerise Biosciences reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.60 Cr.

What is the free cash flow of Amerise Biosciences?

Cash from operations was −₹1.07 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.07 Cr.

Loading…